Other OTC - Delayed Quote • USD
Targeted Medical Pharma, Inc. (TRGM)
At close: July 27 at 10:47 AM EDT
Breakdown
TTM
Total Revenue
5,260.9410
Cost of Revenue
2,095.6810
Gross Profit
3,165.2600
Operating Expense
5,195.0330
Operating Income
-2,029.7730
Net Non Operating Interest Income Expense
-1,173.5650
Other Income Expense
136.1460
Pretax Income
-3,067.1920
Net Income Common Stockholders
-3,043.8100
Diluted NI Available to Com Stockholders
-3,043.8100
Basic EPS
-0.11
Diluted EPS
-0.11
Basic Average Shares
27,218.0490
Diluted Average Shares
27,218.0490
Total Operating Income as Reported
-2,029.7730
Total Expenses
7,290.7140
Net Income from Continuing & Discontinued Operation
-3,043.8100
Normalized Income
-3,179.9560
Interest Expense
1,173.5650
Net Interest Income
-1,173.5650
EBIT
-1,893.6270
EBITDA
-1,662.9570
Reconciled Cost of Revenue
2,095.6810
Reconciled Depreciation
230.6700
Net Income from Continuing Operation Net Minority Interest
-3,043.8100
Total Unusual Items Excluding Goodwill
136.1460
Total Unusual Items
136.1460
Normalized EBITDA
-1,799.1030
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade